etm
www.spandidos-publications.com
Home  | About  | Contact
Spandidos Logo
Advanced Search
Login  | Register


congress_banner

main_table_top_image
   Current Issue Early Online Archive Manuscript Submission About Editor and Editorial Board Sitemap
FDG positron emission tomography/computed tomography findings for the prediction of early recurrence of hepatocellular carcinoma after surgical resection

Authors:
Atsushi Hiraoka, Hironori Ochi, Satoshi Hidaka, Takahide Uehara, Aki Hasebe, Tetsuya Tanihira, Yasunao Miyamoto, Tomoyuki Ninomiya, Hideki Kawasaki, Ichiro Sogabe, Yoshihiro Ishimaru, Masao Miyagawa, Keizo Furuya, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji, Kojiro Michitaka

Affiliations:
Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Surgery, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Radiology, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Pathology, Ehime Prefectural Central Hospital, Ehime 790-0024, Japan, Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan

Published online on:
Wednesday, July 21, 2010

Doi:
10.3892/etm.2010.126

Pages:
829-832

Abstract:

We investigated the predictive value of fluorine-18-fluorodenoxyglucose positron emission tomography/computed tomography for pathological malignant potential and early recurrence of hepatocellular carcinoma (HCC) after resection. From April 2006 to October 2009, 53 patients with naïve HCC were enrolled. Accumulations of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) standardized uptake value (SUVmax) in both HCC and non-HCC areas of the liver as well as the ratio of SUVmax (R-SUV; HCC/liver) were calculated. The results were evaluated to determine prognostic factors for early recurrence. One patient was graded as tumor node metastasis stage I, 35 as II, 14 as III and 3 as stage IV. Elevated protein induced by vitamin K absence or antagonist II (≥200 mAU/ml) as well as elevated fucosylated α-fetoprotein (≥15%), tumor size (≥5 cm) and high R-SUV (≥1.5) were risk factors for early recurrence in a univariate analysis (P<0.05). In a multivariate analysis, high R-SUV (≥1.5) was the only risk factor (P<0.05). The recurrence-free rate in patients with low R-SUV (<1.5, n=34) was higher than that in those with high R-SUV (≥1.5, n=19) (1- and 2-year rates: 100 and 67%, 67 and 17%; respectively, P<0.01). Patients with Edmondson III showed higher R-SUV values than those with Edmondson I and II (3.0±1.8, 1.4±0.3 and 1.9±0.9, respectively, P<0.01), while those with micro-vascular invasion (vp)(+), micro-intrahepatic metastasis (im)(+) or non-boundary type showed higher R-SUV values than vp(-), im(-) and boundary type (3.6±2.4 vs. 2.0±0.9, 3.5±2.3 vs. 1.9±0.8 and 2.9±1.8 vs. 1.6±0.5, respectively, P<0.01). R-SUV is proposed to be a useful marker for the prediction of early recurrence of HCC after resection.

OPEN ACCESS ARTICLE

Experimental and Therapeutic Medicine

September-October 2010
Volume 1 Number 5


Viewing options: Sign up for eToc alerts

Share this article:



main_table_bottom_image